Kei Nakashima

Possible Role for Tocilizumab, an Anti–Interleukin-6 Receptor Antibody, in Treating Cancer Cachexia

Katsutoshi Ando, Fumiyuki Takahashi, Shinji Motojima et al. · Journal of Clinical Oncology · 2012 · 123 citations · Full text

Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies

Ryo Sato, Kosuke Imamura, Shinya Sakata et al. · Journal of Clinical Medicine · 2019 · 83 citations · Full text

Early diagnosis and treatment are crucial for the survival of Pneumocystis pneumonia patients without human immunodeficiency virus infection

Nobuhiro Asai, Shinji Motojima, Yoshihiro Ohkuni et al. · Journal of Infection and Chemotherapy · 2012 · 69 citations

Early Diagnosis, Respiratory Infection, Pneumocystis Pneumonia Patients +3

Low-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia in non-human immunodeficiency virus-infected immunocompromised patients: A single-center retrospective observational cohort study

Kei Nakashima, Masahiro Aoshima, Tamao Nakashita et al. · Journal of Microbiology Immunology and Infection · 2017 · 56 citations · Full text

Diagnostic performance of CT findings for bowel ischemia and necrosis in closed-loop small-bowel obstruction

Kazuaki Nakashima, Hideki Ishimaru, Toshifumi Fujimoto et al. · Abdominal Imaging · 2014 · 55 citations

Ct Findings, Medical Imaging, Bowel Ischemia +10